Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BNT327 |
Trade Name | |
Synonyms | PM8002 |
Drug Descriptions |
BNT327 (PM8002) is a bispecific antibody that targets VEGFA and PD-L1 (CD274), which potentially induces antitumor activity (J Clin Oncol 42, no. 16_suppl (May 29, 2024) 5524). |
DrugClasses | PD-L1/PD-1 antibody 121 VEGFA Antibody 4 |
CAS Registry Number | NA |
NCIT ID | C200259 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BNT327 | BNT327 | 0 | 2 |